SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-020524
Filing Date
2024-03-07
Accepted
2024-03-06 17:42:23
Documents
14
Period of Report
2024-03-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201295-8k_longeveron.htm   iXBRL 8-K 29016
  Complete submission text file 0001213900-24-020524.txt   205027

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lgvn-20240304.xsd EX-101.SCH 3009
3 XBRL LABEL FILE lgvn-20240304_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lgvn-20240304_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0201295-8k_longeveron_htm.xml XML 3713
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 24727300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)